Table 2.
Overall (N=2,771) | Pre (N=632) | Post-1 (N=642) | Post-2 (N=716) | Post-3 (N=781) | P-value | |
---|---|---|---|---|---|---|
April 1, 2012 to March 31, 2020; N (%) | April 1, 2012 to March 31, 2014; N (%) | April 1, 2014 to March 31, 2016; N (%) | April 1, 2016 to March 31, 2018; N (%) | April 1, 2018 to March 31, 2020; N (%) | ||
*tPA use (% of infarcted patients) | 95 (5.7) | 31 (8.5) | 21 (5.5) | 28 (6.6) | 15 (3.0) | 0.018a |
Stroke-related surgery | 357 (12.9) | 105 (16.6) | 74 (11.5) | 86 (12.0) | 92 (11.8) | 0.017 |
Tracheostomy | 50 (1.8) | 15 (2.4) | 16 (2.5) | 9 (1.3) | 10 (1.3) | 0.152 |
Gastrostomy | 54 (1.9) | 14 (2.2) | 17 (2.6) | 15 (2.1) | 8 (1.0) | 0.143 |
Rehabilitation | 2525 (91.1) | 572 (90.5) | 587 (91.4) | 637 (89.0) | 729 (93.3) | 0.026b |
Dental treatment/care | 944 (34.1) | 141 (22.3) | 214 (33.3) | 270 (37.7) | 319 (40.8) | P<0.0001c |
Intervention within 7 days of hospitalization | 527 (19.0) | 47 (7.4) | 123 (19.2) | 139 (19.4) | 218 (27.9) | P<0.0001d |
Notes: *tPA: tissue-type plasminogen activator. All comparisons used the Pearson’s chi-square test, and multiple comparisons used Bonferroni’s adjustment. aP=0.002: Pre vs. Post-3. bP=0.003: Post-2 vs. Post-3. cP<0.001: Pre vs. Post-1, Post-2, and Post-3; P=0.004: Post-1 vs. Post-3. dP<0.001: Pre vs. Post-1, Post-2, and Post-3; Post 1 vs. Post-3; and Post-2 vs. Post-3.